Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 376 - 400 of 475 in total
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
Experimental
Matched Categories: … Selenium Compounds …
An organoselenium drug previously studied by Oxis International in Phase-II clinical trials for ulcerative colitis patients. Some indications of efficacy were demonstrated. BXT-51072 has enthusiastic endorsement for treatment in cardiovascular indications, primarily because of its ability to mimic the function of glutathione peroxidase.
Investigational
Matched Categories: … Selenium Compounds …
Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).
Investigational
Matched Categories: … Selenium Compounds …
Cystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis).
Investigational
Matched Categories: … Ion Pumps ... Ion Channels …
IONIS-HBVRx is under investigation in clinical trial NCT04544956 (A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B).
Investigational
GsMtx-4 is a peptide found in tarantula venom that inhibits mechanosensitive ion channel (MSC) activity.
Investigational
Matched Description: … GsMtx-4 is a peptide found in tarantula venom that inhibits mechanosensitive ion channel (MSC) activity …
Methylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.
Investigational
Matched Categories: … Selenium Compounds …
Sapablursen is a synthetic 2'-O-(2-methoxyethyl)-modified antisense oligonucleotide linked to a tri-antennary cluster of N-acetyl galactosamine (GalNAc3) sugars targeting transmembrane protease, serine 6 messenger ribonucleic acid
Investigational
Experimental
Matched Iupac: … iron(3+) ion trihydroxide …
Experimental
Matched Iupac: … (67Ga)gallium(3+) ion
Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Iupac: … lambda5-antimony(5+) ion
Experimental
Matched Iupac: … magnesium(2+) ion dioxidanediide …
Experimental
Matched Iupac: … dicerium(3+) ion trioxalate …
Experimental
Matched Iupac: … (89Sr)strontium(2+) ion
Experimental
Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to DB00545 and DB01400. It is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors. Distigmine is available in several countries...
Experimental
CNS 5161 is a blocker of the NMDA ion channel and has completed Phase IIa proof of concept clinical trials as a novel compound for the treatment of neuropathic pain.
Investigational
Matched Description: … CNS 5161 is a blocker of the NMDA ion channel and has completed Phase IIa proof of concept clinical trials …
Aluminium acetoacetate is an aluminum containing antacid.
Experimental
Matched Iupac: … aluminium(3+) ion tris(3-oxobutanoate) …
Experimental
Vet approved
Matched Iupac: … dibismuth(3+) ion carbonate dioxidandiide …
Displaying drugs 376 - 400 of 475 in total